Stewart West Indies Trading Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$42.8M Hold
1,272,283
3.71% 9
2017
Q4
$43.7M Hold
1,272,283
3.69% 10
2017
Q3
$43.1M Hold
1,272,283
3.76% 10
2017
Q2
$40.5M Hold
1,272,283
3.54% 11
2017
Q1
$41.3M Hold
1,272,283
3.57% 10
2016
Q4
$39.2M Hold
1,272,283
3.49% 10
2016
Q3
$40.9M Hold
1,272,283
3.91% 11
2016
Q2
$42.5M Hold
1,272,283
4.1% 9
2016
Q1
$35.8M Hold
1,272,283
3.56% 11
2015
Q4
$39M Hold
1,272,283
4.02% 9
2015
Q3
$37.9M Hold
1,272,283
3.99% 9
2015
Q2
$40.5M Buy
1,272,283
+396,936
+45% +$12.9M 4.1% 9
2015
Q1
$28.9M Buy
875,347
+71,988
+9% +$2.29M 2.8% 11
2014
Q4
$23.7M Buy
803,359
+122,159
+18% +$3.5M 2.26% 13
2014
Q3
$19.1M Buy
+681,200
New +$19.1M 1.91% 16

Other funds holding PFE

Stewart West Indies Trading Company's PFE Position: Q1 2018 in Review

Stewart West Indies Trading Company held its Pfizer (PFE) position steady in Q1 2018 at 1,272,283 shares worth $42.8M. The position accounts for 3.71% of the portfolio, ranked #9.

Stewart West Indies Trading Company first reported a position in PFE in Q3 2014 and has held it in 15 quarters since. The position peaked at $43.7M in Q4 2017. 2,230 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • Stewart West Indies Trading Company held 1,272,283 shares of Pfizer worth $42.8M as of Q1 2018.
  • Stewart West Indies Trading Company left its Pfizer share count unchanged in Q1 2018.
  • Pfizer made up 3.71% of Stewart West Indies Trading Company's portfolio in Q1 2018, its #9 holding.
  • Stewart West Indies Trading Company first reported a position in Pfizer in Q3 2014 and has held it in 15 quarters since.
  • Stewart West Indies Trading Company's Pfizer position peaked at $43.7M in Q4 2017.
  • 2,230 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Stewart West Indies Trading Company's 13F filing for Q1 2018, filed 15 May 2018.